Amplification of lipopolysaccharide-induced cytokine synthesis in non-small cell lung cancer/neutrophil cocultures

Molecular Cancer Research

Volumn 7, Issue 10, 2009, Pages 1729-1735

  Grandel, Ulrich ^a   Heygster, Diana ^a   Sibelius, Ulf ^a   Fink, Ludger ^a   Sigel, Stefanie ^b   Seeger, Werner ^a   Grimminger, Friedrich ^a   Hattar, Katja ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 2; INTERLEUKIN 6; INTERLEUKIN 8; LIPOTEICHOIC ACID; MESSENGER RNA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER GROWTH; CELL CONTACT; CELL TYPE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TIME;

CARCINOMA, NON-SMALL-CELL LUNG; CELL COMMUNICATION; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; COCULTURE TECHNIQUES; CYCLOOXYGENASE 2 INHIBITORS; CYTOKINES; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; NEUTROPHILS; PNEUMONIA, BACTERIAL; RNA, MESSENGER; TEICHOIC ACIDS; TIME FACTORS; TRANSCRIPTIONAL ACTIVATION;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 72449201690     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0048     Document Type: Article

References (45)

1. Perlin E, Bang KM, Shah A, et al. The impact of pulmonary infections on the survival of lung cancer patients. Cancer 1990;66:593-596 (Pubitemid 20233462)
2. Putinati S, Trevisani L, Gualandi M, et al. Pulmonary infections in lung cancer patients at diagnosis. Lung Cancer 1994;11:243-249 (Pubitemid 24289176)
3. Berghmans T, Sculier JP, Klastersky J. A prospective study of infections in lung cancer patients admitted to the hospital. Chest 2003;124:114-120 (Pubitemid 36851341)
4. Sakamoto M, Mikasa K, Majima T, et al. Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer. Chemotherapy 2001;47:444-451 (Pubitemid 34062872)
5. Mager DL. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med 2006;28:4-14.
6. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659-672
7. Littmann AJ, Jackson L, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 2005;14:773-778 (Pubitemid 40478534)
8. Gioannini TL, Weiss JP. Regulation of interaction of Gram-negative bacterial endotoxins with mammalian cells. Immunol Res 2007;39:249-260
9. Ginsburg I. Role of lipoteichioc acid in infection and inflammation. Lancet Infect Dis 2002:171-179 (Pubitemid 34462452)
10. Zeytun A, van Velkinburgh JC, Pardington PE, Cary RR, Gupta G. Pathogen-specific innate immune response. Adv Exp Med Biol 2007:342-357
11. Reutershan J, Ley K. Bench to bedside review: acute respiratory distress syndrome: how neutrophils migrate into the lung. Crit Care 2004;8:453-461 (Pubitemid 40073680)
12. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Stricter RM. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996;97:2792-2802 (Pubitemid 26197092)
13. Luppi F, Lungo AM, de Boer WI, Rabe KF, Hiemstra PS. Interleukin 8 stimulates proliferation in non small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 2007;56:25-33. (Pubitemid 46356635)
14. Zhu YM, Webster SJ, Flower D, Woll PJ. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer;91:1970-6.
15. Yuan A, Yang PC, Yu CJ, et al. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med 2000;162:1957-1963 (Pubitemid 30947587)
16. De Vita F, Orditura M, Auriemma A, Infusino S, Roscigno A, Catalano G. Serum levels of interleukin-6 as a prognostic factor in non-small-cell lung cancer. Oncol Rep 1998;5:649-652 (Pubitemid 28189321)
17. Bihl M, Tamm M, Nauck M, Wieland H, Perruchoud AP, Roth M. Proliferation of human non-small-cell lung cancer cell lines: role of interleukin-6. Am J Respir Cell Mol Biol 1998:606-612 (Pubitemid 128354242)
18. Yamaji H, Iizasa T, Koh E, et al. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol Immunother 2004;53:786-792 (Pubitemid 39149905)
19. Dinarello CA. The paradox of proinflammatory cytokines in cancer. Cancer Metastasis Rev 2006;25:307-313
20. Bellocq A, Antoine M, Flahault A, et al. Neutrophil alveolitis in bronchoalveolar carcinoma. Induction by tumor derived interleukin 8 and relation to clinical outcome. Am J Pathol 1998;152:83-92. (Pubitemid 28028049)
21. Wislez M, Philippe C, Antoine M, et al. Upregulation of bronchioloalveolar carcinoma-derived C-X-C chemokines by tumor infiltrating inflammatory cells. Inflamm Res 2004;53:004-12. (Pubitemid 38121831)
22. Henriquet C, Gougat-Barbera C, Comes A, Lazennec G, Mathieu M. Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells. Lung Cancer 2007;56:167-174 (Pubitemid 46590485)
23. Castelao JE, Bart R, DiPerna CA, Sievers EM, Bremner RM. Lung cancer and cyclooxygenase-2. Ann Thorac Surg 2003;76:1327-1335
24. Yuan A, Yu CJ, Shun CT, et al. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Int J Cancer 2005;115:545-555 (Pubitemid 40656711)
25. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimãki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998; 58:4997-5001. (Pubitemid 28521147)
26. Chang HC, Weng CF. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells. Oncol Rep 2001;8:1321-1325
27. Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med 2001;193:23-26
28. Anderson IC, Mari SE, Broderick RJ, Mari BP, Shipp MA. The angiogenic factor interleukin-8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures. Cancer Res 2000;60:269-272
29. Kasuga I, Makino S, Kiyokawa H, Katho H, Ebihara Y, Ohyashiki K. Tumor related leukocytosis is linked with a poor prognosis in patients with lung carcinoma. Cancer 2001;92:2399-2405. (Pubitemid 33029085)
30. Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999;73:369-505.
31. Jagels MA, Daffern PJ, Zuraw BL, Hugli TE. Mechanisms and regulation of polymorphonuclear leukocyte and eosinophil adherence to human airway epithelial cells. Am J Respir Cell Mol Biol 1999;21:418-427
32. Krunkosky TM, Jarrett CL. Selective regulation of MAP kinases and chemokine expression after ligation of ICAM-1 on human airway epithelial cells. Respir Res 2006;3:7-12.
33. Standiford TJ, Kunkel SL, Basha MA, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 1990;86:1945-1953
34. Jiang Z, Kunimoto M, Patel A. Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytical virus. J Virol 1998;72:2496-2499 (Pubitemid 28100812)
35. Fukuyama T, Ichiki Y, Yamada S, et al. Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/ immunological responses both in vivo and in vitro. Cancer Sci 2007;98:1048-1054 (Pubitemid 46865390)
36. Burvall K, Palmberg L, Larsson K. Expression of TNF α and its receptors R1 and R2 in human alveolar epithelial cells exposed to organic dust and the effect of 8-bromo-cAMP and protein kinase A modulation. Inflamm Res 2005;54:281-288 (Pubitemid 41185489)
37. Põld M, Zhu LX, Sharma S, et al. Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC ligand (CXCL) 5 and interleukin- 8/CXCL8 in human non-small cell lung cancer. Cancer Res 2004;64:1853-1860.
38. Shishodia S, Koul D, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-κB activation through inhibition of activation of IκBκ kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol 2004;173:2011-2022 (Pubitemid 38971638)
39. Surette ME, Dallaire N, Jean N, Picard S, Borgeat P. Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils. FASEB J 1998;12:1521-1531 (Pubitemid 28506721)
40. Bren-Mattison Y, Meyer AM, Van Putten V, et al. Antitumorigenic effects of peroxisome proliferator-activated receptor-γ in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-κB. Mol Pharmacol 2008;73:709-717
41. Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E. Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer. Cancer Invest 2006;24:492-496 (Pubitemid 44576401)
42. Morath S, Geyer A, Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid. J Exp Med 2001;193:393-397
43. Draing C, Sigel S, Deininger S, et al. Cytokine induction by Gram-positive bacteria. Immunobiology 2008;213:285-296
44. Grimminger F, Hattar K, Papavassilis C, et al. Neutrophil activation by antiproteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic 7acid and leukotriene B4 generation. J Exp Med 1996;184:1567-1572 (Pubitemid 26354715)
45. Fink L, Seeger W, Ermert L, et al. Real-time quantitative RT-PCR after laserassisted cell picking. Nat Med 1998;4:1329-1333 (Pubitemid 28512117)